Blood Group Typing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Blood Group Typing Market, By Product

7.1.  Blood Group Typing Market, By Product, 2021-2028

7.1.1.    Consumables

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Instruments

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Services

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Blood Group Typing Market, By Technique

8.1.  Blood Group Typing Market, By Technique, 2021-2028

8.1.1.    PCR-based and Microarray Techniques

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Assay-based Techniques

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Massively Parallel Sequencing Techniques

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Other Techniques

8.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Blood Group Typing Market, By Test Type

9.1.  Blood Group Typing Market, By Test Type, 2021-2028

9.1.1.    Antibody Screening

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    HLA Typing

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Cross-matching Tests

9.1.3.1.        Market Revenue and Forecast (2016-2028)

9.1.4.    ABO Blood Tests

9.1.4.1.        Market Revenue and Forecast (2016-2028)

9.1.5.    Antigen Typing

9.1.5.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Blood Group Typing Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Product (2016-2028)

10.1.2.  Market Revenue and Forecast, By Technique (2016-2028)

10.1.3.  Market Revenue and Forecast, By Test Type (2016-2028)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Product (2016-2028)

10.1.4.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.1.4.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Product (2016-2028)

10.1.5.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.1.5.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Product (2016-2028)

10.2.2.  Market Revenue and Forecast, By Technique (2016-2028)

10.2.3.  Market Revenue and Forecast, By Test Type (2016-2028)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Product (2016-2028)

10.2.4.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.2.4.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Product (2016-2028)

10.2.5.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.2.5.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Product (2016-2028)

10.2.6.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.2.6.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Product (2016-2028)

10.2.7.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.2.7.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Product (2016-2028)

10.3.2.  Market Revenue and Forecast, By Technique (2016-2028)

10.3.3.  Market Revenue and Forecast, By Test Type (2016-2028)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Product (2016-2028)

10.3.4.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.3.4.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Product (2016-2028)

10.3.5.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.3.5.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Product (2016-2028)

10.3.6.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.3.6.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Product (2016-2028)

10.3.7.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.3.7.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Product (2016-2028)

10.4.2.  Market Revenue and Forecast, By Technique (2016-2028)

10.4.3.  Market Revenue and Forecast, By Test Type (2016-2028)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Product (2016-2028)

10.4.4.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.4.4.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Product (2016-2028)

10.4.5.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.4.5.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Product (2016-2028)

10.4.6.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.4.6.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Product (2016-2028)

10.4.7.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.4.7.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Product (2016-2028)

10.5.2.  Market Revenue and Forecast, By Technique (2016-2028)

10.5.3.  Market Revenue and Forecast, By Test Type (2016-2028)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Product (2016-2028)

10.5.4.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.5.4.3.      Market Revenue and Forecast, By Test Type (2016-2028)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Product (2016-2028)

10.5.5.2.      Market Revenue and Forecast, By Technique (2016-2028)

10.5.5.3.      Market Revenue and Forecast, By Test Type (2016-2028)

Chapter 11.  Company Profiles

11.1.              Grifols, S.A.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Merck KGaA

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Bio-Rad Laboratories, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Immucor, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Novacyt Group

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Danaher Corporation

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Agena Bioscience, Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Ortho Clinical Diagnostics

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Quotient, Ltd.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Report Details

  • Report Code:36939
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:January 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers